Indispensable role of microbes in anticancer drugs and discovery trends
- PMID: 35819512
- DOI: 10.1007/s00253-022-12046-2
Indispensable role of microbes in anticancer drugs and discovery trends
Abstract
Recent years have seen an increased focus on the advancement of naturally derived products for the treatment of cancer. Since the beginning of recorded history, nature has provided a variety of medicinal agents, and an overwhelming number of drugs that we have today are derived from natural sources. Such natural agents are prominently used to treat several diseases such as diabetes, malaria, Alzheimer's, pulmonary disorders, etc. with cancer being the highlight of this review. Due to the rapid development of resistance to chemotherapeutic drugs, the hunt for effective novel drugs is still a paramount concern in cancer treatment. Moreover, many chemotherapy drugs typically have high toxicity and adverse side effects, which necessitates the need to develop anti-tumor drugs that can be employed to treat deadly tumors with fewer negative effects on health and better efficacy. Isolation of several chemotherapeutic drugs has been conducted from a wide range of natural sources which include plants, microbes, fungi, and marine microorganisms. Considering the trends of previous decades, microbial diversity has grown to play a significant role in the formulation of pharmaceuticals and drugs, especially antibiotics and anti-cancer medications. Microbe-derived antitumor antibiotics such as anthracycline, epothilones, bleomycin, actinomycin, and staurosporine are amongst the widely used cancer chemotherapeutic agents. This review deals majorly with microbe-derived anticancer drugs taking into account their derivatives, mechanism of action, isolation procedures, limitations, and tumors targeted by them. This article also reports the phase of clinical study these drugs are undergoing. Moreover, it intends to portray the indispensable part that these microbes have been playing since time immemorial in the odyssey of chemotherapeutic agents. KEY POINTS: • Microbial diversity contributes heavily towards the formulation of anticancer drugs. • Polypeptides, carbohydrates, and alkaloids are prevalent microbe-based drug classes. • Microbe-derived anticancer agents target various sarcomas, carcinomas, and lymphomas.
Keywords: Chemotherapeutic agents; Clinical trials; Extraction methods; Microbe-derived drugs; Targeted tumors.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Anticancer agents from diverse natural sources.Nat Prod Commun. 2014 Nov;9(11):1655-69. Nat Prod Commun. 2014. PMID: 25532303 Review.
-
Natural products for cancer chemotherapy.Microb Biotechnol. 2011 Nov;4(6):687-99. doi: 10.1111/j.1751-7915.2010.00221.x. Epub 2010 Nov 18. Microb Biotechnol. 2011. PMID: 21375717 Free PMC article. Review.
-
Bacteria as a treasure house of secondary metabolites with anticancer potential.Semin Cancer Biol. 2022 Nov;86(Pt 2):998-1013. doi: 10.1016/j.semcancer.2021.05.006. Epub 2021 May 9. Semin Cancer Biol. 2022. PMID: 33979675 Review.
-
Adverse drug reactions of anticancer drugs derived from natural sources.Food Chem Toxicol. 2019 Jan;123:522-535. doi: 10.1016/j.fct.2018.11.041. Epub 2018 Nov 22. Food Chem Toxicol. 2019. PMID: 30471312 Review.
-
Cancer Chemotherapy via Natural Bioactive Compounds.Curr Drug Discov Technol. 2022;19(4):e310322202888. doi: 10.2174/1570163819666220331095744. Curr Drug Discov Technol. 2022. PMID: 35362385 Review.
Cited by
-
Relationships of Prodiginins Mechanisms and Molecular Structures to their Antiproliferative Effects.Anticancer Agents Med Chem. 2024;24(19):1383-1395. doi: 10.2174/0118715206314212240805105735. Anticancer Agents Med Chem. 2024. PMID: 39113301 Review.
-
Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials.Arch Microbiol. 2024 Oct 29;206(11):449. doi: 10.1007/s00203-024-04179-x. Arch Microbiol. 2024. PMID: 39472338 Review.
-
Marine Streptomyces-Derived Novel Alkaloids Discovered in the Past Decade.Mar Drugs. 2024 Jan 22;22(1):51. doi: 10.3390/md22010051. Mar Drugs. 2024. PMID: 38276653 Free PMC article. Review.
-
Investigating the Anticancer Properties of Bacterial Toxoid in Combination Vaccines.Asian Pac J Cancer Prev. 2025 Jan 1;26(1):233-238. doi: 10.31557/APJCP.2025.26.1.233. Asian Pac J Cancer Prev. 2025. PMID: 39874006 Free PMC article.
-
Targeted inhibition of the PI3K/AKT/mTOR pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer.Cell Mol Biol Lett. 2024 Apr 23;29(1):58. doi: 10.1186/s11658-024-00578-6. Cell Mol Biol Lett. 2024. PMID: 38649803 Free PMC article.
References
-
- Abdelmohsen UR, Szesny M, Othman EM, Schirmeister T, Grond S, Stopper H, Hentschel U (2012) antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar Drugs 10:2208–2221. https://doi.org/10.3390/md10102208 - DOI - PubMed - PMC
-
- Abdelmohsen UR, Bayer K, Hentschel U (2014) Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat Prod Rep 31:381–399. https://doi.org/10.1039/C3NP70111E - DOI - PubMed
-
- Abdel-Razek AS, El-Naggar ME, Allam A, Morsy OM, Othman SI (2020) Microbial natural products in drug discovery. Processes 8:470. https://doi.org/10.3390/pr8040470 - DOI
-
- Adhikari A, Teijaro CN, Townsend CA, Shen B (2020) Biosynthesis of enediyne natural products. In: Comprehensive Natural Products III, Elsevier, pp 365–414. https://doi.org/10.1016/B978-0-12-409547-2.14651-7
-
- Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang K, Fonstein L, Czisny A, Whitwam RE, Farnet CM, Thorson JS (2002) The calicheamicin gene cluster and its iterative type i enediyne pks. Science 297:1173–1176. https://doi.org/10.1126/science.1072105 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical